Clinical trial
A Study of the Tumor Microenvironment Affecting the Efficacy of Immunotherapy for Esophageal Cancer
NCT06219031 is registered in ClinicalTrials.gov with Renmin Hospital of Wuhan University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study of the Tumor Microenvironment Affecting the Efficacy of Immunotherapy for Esophageal Cancer
- Lead sponsor
- Renmin Hospital of Wuhan University
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 1, 2023
- Completion date
- January 1, 2024
- Enrollment
- 22 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
esophageal cancer